Northern Trust’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
112,191
-9,585
-8% -$152K ﹤0.01% 3245
2026
Q1
$1.96M Buy
121,776
+2,087
+2% +$36.3K ﹤0.01% 2986
2025
Q4
$2.21M Buy
119,689
+4,046
+3% +$73.9K ﹤0.01% 2940
2025
Q3
$2.08M Sell
115,643
-20,063
-15% -$370K ﹤0.01% 3018
2025
Q2
$2.63M Sell
135,706
-11,263
-8% -$212K ﹤0.01% 2836
2025
Q1
$2.28M Buy
146,969
+2,201
+2% +$39.4K ﹤0.01% 2849
2024
Q4
$2.58M Buy
144,768
+70,367
+95% +$1.21M ﹤0.01% 2879
2024
Q3
$1.34M Buy
+74,401
New +$1.36M ﹤0.01% 3224

Other funds holding MDWD

Northern Trust's MDWD Position: Q2 2026 in Review

Northern Trust reduced its MediWound (MDWD) stake by 7.9% in Q2 2026, selling an estimated $152K and leaving 112,191 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3245.

Northern Trust first reported a position in MDWD in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.63M in Q2 2025. 78 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Northern Trust held 112,191 shares of MediWound worth $1.65M as of Q2 2026.
  • Northern Trust sold 9,585 MediWound shares in Q2 2026, an estimated $152K.
  • MediWound made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3245 holding.
  • Northern Trust first reported a position in MediWound in Q3 2024 and has held it in 8 quarters since.
  • Northern Trust's MediWound position peaked at $2.63M in Q2 2025.
  • 78 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.